DSP Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹3138 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 18% |
| Expense Ratio | 2.35 | 1.92 |
| Manager | Rohan Korde | Jay Kothari |
| ISIN Code | INF00XX01BL5 | INF740KA1LD8 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | -4.47% | -0.44% |
| 6 Month | 11.67% | 15.85% |
| 1 Year | 27.54% | 32.63% |
| 3 Year | 18.15% | 22.36% |
| 5 Year | - | 28.35% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 20.98% | 27.73% |
| 3 Year | 27.81% | 32.42% |
| 5 Year | - | 26.22% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 22.17% | 27.85% |
| 3 Year | 19.97% | 20.38% |
| 5 Year | - | 27.14% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.69% |
| Sharp | - | 0.76% |
| Beta | - | 0.93% |
| Alpha | - | 3.36% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Rohan Korde | Jay Kothari |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Fund Manage | 10 | 20 |
| ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.8 | 17.61 |
| Large Cap | 38.11 | 22.07 |
| Mid Cap | 26.43 | 18.45 |
| Small Cap | 33.66 | 41.87 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.8 | 17.61 |
| Pharmaceuticals & Biotechnology | 77 | 68.54 |
| Healthcare Services | 18.01 | 11.97 |
| Chemicals & Petrochemicals | 0.96 | - |
| Fertilizers & Agrochemicals | 1.03 | - |
| Insurance | 1.2 | 1.47 |
| Retailing | - | 0.41 |
Top Comparisons
Sundaram Financial Services Opportunities Fund Regular Plan - Growth
3Y Returns14.97%
Quant BFSI Fund Regular - Growth
3Y Returns0%
DSP Gilt Fund - Regular Plan - Growth
3Y Returns6.73%
UTI - Gilt Fund - Regular Plan - Growth Option
3Y Returns6.33%
Kotak NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns18.73%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns12.09%
Tata Large Cap Fund -Regular Plan - Growth Option
3Y Returns11.69%
Tata Large Cap Fund -Regular Plan - Growth Option
3Y Returns11.69%